TaurelFinance, decoded
Live
Loading market data…
TTaurel

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

Investing.com· Reuters· Jun 22, 2026 · 12:24 PM
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

European shares rise on banking boost
stocksabout 1 hour ago

European shares rise on banking boost

Investing.com

Genmab shares rise 4% on J&J cancer drug FDA approval
stocksabout 1 hour ago

Genmab shares rise 4% on J&J cancer drug FDA approval

Investing.com

Outokumpu shares fall 5% after JPMorgan downgrade
stocksabout 1 hour ago

Outokumpu shares fall 5% after JPMorgan downgrade

Investing.com